Compare · FLNC vs TMO
FLNC vs TMO
Side-by-side comparison of Fluence Energy Inc. (FLNC) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- FLNC operates in Miscellaneous, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $257.53B, about 217.0x FLNC ($1.19B).
- Over the past year, FLNC is down 68.3% and TMO is up 28.0% - TMO leads by 96.3 points.
- FLNC has been more active in the news (9 items in the past 4 weeks vs 7 for TMO).
- Both have 25 recent analyst ratings on file.
- Company
- Fluence Energy Inc.
- Thermo Fisher Scientific Inc
- Price
- $5.80-9.86%
- $690.13-0.92%
- Market cap
- $1.19B
- $257.53B
- 1M return
- -24.12%
- +4.77%
- 1Y return
- -68.32%
- +28.01%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 9
- 7
- Recent ratings
- 25
- 25
Fluence Energy Inc.
Fluence Energy, Inc. provides energy storage products and services, and digital applications for renewables and storage applications worldwide. The company sells energy storage products with integrated hardware, software, and digital intelligence, as well as engineering and delivery services to support the deployment of its storage products; operational and maintenance, and energy storage-as-a-service; and digital applications and solutions. It serves utilities, developers, and commercial and industrial customers. The company was founded in 2018 and is headquartered in Arlington, Virginia. Fluence Energy, LLC operates as a subsidiary of Siemens Aktiengesellschaft and The AES Corporation.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest FLNC
- Levi & Korsinsky Reminds Fluence Energy, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 27, 2026 - FLNC
- Vattenfall Awards 1 GWh Brunsbüttel Battery Storage Project to Fluence
- SEC Form 8-K filed by Fluence Energy Inc.
- FLNC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Fluence Energy, Inc. Securities Lawsuit - Contact Levi & Korsinsky
- Fluence Secures Long-Term Battery Supply Through Multiyear Agreement with EVE Power
- Director Bulls Herman E bought $73,600 worth of shares (10,000 units at $7.36), increasing direct ownership by 6% to 169,550 units (SEC Form 4)
- Director Von Heynitz Harald bought $51,520 worth of shares (7,000 units at $7.36), increasing direct ownership by 12% to 65,550 units (SEC Form 4)
- SEC Form 3 filed by new insider Coughlin Stephen
- SEC Form 3 filed by new insider Da Santos Bernerd
- Fluence downgraded by Jefferies with a new price target
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)